FASTinov featured in the SPPC 2022 webinar “The role of next generation rapid-AST technologies in the modern response to sepsis”
FASTinov technology is discussed in the webinar organized by the Portuguese Society of Clinical Pathology (link here), on October 12, 2022. The webinar is moderated by Dr. Luís Nogueira Martins and presented by Prof. Dr. Rafael Cantón (Hosp. Ramón Y Cajal – Madrid) and Dr. Carlos Palos (Grupo Luz Saúde).
The main topics will be the importance of speed in sepsis response, and the recent developments in ultra-rapid susceptibility testing, and how this changes the microbiology response.
The SPPC 2022 are a series of online training webinars organized by the Society, with a sequence of 10 themes of impact in the field of laboratorial sciences.
FASTinov has developed ultra-rapid, phenotypic antibiotic susceptibility tests for bloodstream infections that deliver antibiograms in less than 2 hours, based upon patented technologies. The company is based in Porto, Portugal.
Share with friends